Rights and permissions
About this article
Cite this article
Should Australia introduce lamivudine for chronic hep B?. Pharmacoecon. Outcomes News 270, 7 (2000). https://doi.org/10.1007/BF03275512
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03275512